Clinical Trials Browser

Phase 1/2 × tafasitamab × Other hematologic neoplasm × Clear all

Leukemia, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

Hematologic Neoplasms